Evaluating cenerimod for moderate-to-severe systemic lupus

ClinicalTrials.gov identifier: NCT05648500

This Phase 3 clinical study evaluates cenerimod in adults with moderate-to-severe systemic lupus erythematosus receiving background therapy.

Study availability and enrollment status may change. A California Research Institute coordinator can confirm current local availability and explain the screening process.